Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 07, 2019	CT ORDER	CT ORDER	View HTML 9999999997-19-003999.pdf
May 03, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0000930413-19-001557.pdf 0000930413-19-001557.xls
Apr 26, 2019	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000930413-19-001350.pdf 0000930413-19-001350.xls
Apr 26, 2019	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-19-001351.pdf 0000930413-19-001351.xls
Apr 26, 2019	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-19-001352.pdf 0000930413-19-001352.xls
Apr 18, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000011.pdf 0001237899-19-000011.xls
Apr 10, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0000930413-19-001187.pdf 0000930413-19-001187.xls
Mar 22, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-19-000008.pdf 0001708138-19-000008.xls
Mar 12, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001140361-19-004808.pdf 0001140361-19-004808.xls
Feb 14, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001422849-19-000108.pdf

Data provided by Kaleidoscope.

Investors & Media